Jodi L. Vogel

National Institutes of Health — United States

Medicine · Health Sciences

19h-index1.8kcitations48works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Herpesvirus Infections and Treatments(16), Cytomegalovirus and herpesvirus research(6), Virus-based gene therapy research(5), Toxin Mechanisms and Immunotoxins(4), HIV Research and Treatment(3)

Publications48 total

The H4K20-mono-methyltransferase SETD8 promotes global accessibility of infecting herpes simplex virus genomes
Journal of Virology·2025Open Access
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies
Science Translational Medicine·2025· 1 citedOpen Access
Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodies
2024· 1 citedOpen Access
Deletion of the Transcriptional Coactivator HCF-1 <i>In Vivo</i> Impairs the Removal of Repressive Heterochromatin from Latent HSV Genomes and Suppresses the Initiation of Viral Reactivation
mBio·2023· 9 citedOpen Access
Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation
UNC Libraries·2020Open Access
Inhibition of the Super Elongation Complex Suppresses Herpes Simplex Virus Immediate Early Gene Expression, Lytic Infection, and Reactivation from Latency
mBio·2020· 16 citedOpen Access
The Cellular Coactivator HCF-1 Is Required for Glucocorticoid Receptor-Mediated Transcription of Bovine Herpesvirus 1 Immediate Early Genes
Journal of Virology·2018· 17 citedOpen Access
Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation
Cell Host & Microbe·2015· 162 citedOpen Access
Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes
Science Translational Medicine·2014· 86 citedOpen Access
Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imaging
Virology·2013· 38 citedOpen Access
Table 1, LSD1 histone demethylaseassay protocol
2013
Figure 11, [(A) Viral IE (ICP4, ICP27,...].
2013
Figure 14, [(A) Viral yields from HSV-1...].
2013
Figure 6, Plate Z' trend for the JMJD2E primary qHTS
2013
Figure 12, [(A) MRC-5 cells were treated...].
2013
Scheme 1, Synthetic route for analogs containing 5-COOH
2013
Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity
2013· 28 cited
Figure 15, MRC-5 cells were treated with DMSO or 50 mM ML324 for 3 hr, followed by infection with hCMV (0.1 pfu/cell) for 5 hr
2013
Figure 1, Previously reported inhibitors of JMJD histone demethylases
2013
Table 4, ADME profile for ML324
2013
page 1 of 3Next →

Frequent Co-authors

Thomas M. Kristie(39), Jesse H. Arbuckle(22), Ganesha Rai(17), Ajit Jadhav(17), David J. Maloney(17), Anton Simeonov(16), Anthony Tumber(16), Nathan R. Rose(16), Thomas S. Dexheimer(16), Timothy L. Foley(16), Oliver N. F. King(16), Bryan T. Mott(16), Christopher J. Schofield(16), Udo Oppermann(16), Amy Quinn(13), Akane Kawamura(11), Yu Liang(6), Yu Liang(5), Akane Kawamura(3), Amy C. Dechen Quinn(3)